Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lawrence Corey
HVTN; FHCRC
Study Chair - Myron Cohen
HPTN; University of North Carolina
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto de Pesquisa Clinica Evandro Chagas (ipec) Crs
Rio de Janeiro, Brazil
- Acsa Crs
Iquitos, Maynas, Peru
- Citbm - Unidec, Centro de Investigaciones Tecnológicas, Biomédicas Y Medioambientales Crs
Bellavista, Provincia Constitucional del Callao, Peru
- Barranco Crs
Lima, Peru
- San Miguel Crs
Lima, Peru
- Via Libre Crs
Lima, Peru
- Lausanne Vaccine and Immunotherapy Center Crs
Lausanne, Canton of Vaud, Switzerland
- Alabama Crs
Birmingham, Alabama, United States
- Ucla Vine Street Clinic Crs
Los Angeles, California, United States
- Bridge Hiv Crs
San Francisco, California, United States
- George Washington Univ. Crs
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- the Hope Clinic of the Emory Vaccine Center Crs
Decatur, Georgia, United States
- Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)
Boston, Massachusetts, United States
- Fenway Health (fh) Crs
Boston, Massachusetts, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Columbia P&s Crs
New York, New York, United States
- Harlem Prevention Center Crs
New York, New York, United States
- New York Blood Center Crs
New York, New York, United States
- University of Rochester Vaccines To Prevent Hiv Infection Crs
Rochester, New York, United States
- Bronx Prevention Research Center Crs
The Bronx, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Penn Prevention Crs
Philadelphia, Pennsylvania, United States
- Vanderbilt Vaccine (vv) Crs
Nashville, Tennessee, United States
- Seattle Vaccine and Prevention Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Apr 2016
- Primary completion
- 1 Dec 2020
- Completion
- 1 Dec 2020
- Last update posted
- 23 Feb 2022
- Registered enrollment
- 2,699
- Registry id
- NCT02716675
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.